
US Rep Kathy Castor @USRepKCastor
Big pharma often keeps drug prices high by deliberately delaying the entrance of generic drugs into the market through various “pay to delay” schemes. See how we are working to address that problem today during my @EnergyCommerce Subcommittee on Health hearing 👇 https://t.co/eHVAeF4Avq — PolitiTweet.org